These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


45 related items for PubMed ID: 3404666

  • 1. [Inhibitory effect of deferoxamine on DNA synthesis in the lymphoid cell lines].
    Kodama M, Hanada S, Kuwazuru Y, Saito T, Uozumi K, Makino T, Terada A, Hashimoto S.
    Rinsho Ketsueki; 1988 Apr; 29(4):502-6. PubMed ID: 3404666
    [No Abstract] [Full Text] [Related]

  • 2. Inhibitory effect of dipyridamole on the growth of various human hematologic malignant cell lines.
    Hirose M, Takeda E, Ninomiya T, Kuroda Y, Miyao M.
    Tokushima J Exp Med; 1986 Dec; 33(3-4):51-7. PubMed ID: 3448793
    [No Abstract] [Full Text] [Related]

  • 3. Correspondence Re: David L. Becton and Barbara Roberts. Antileukemic effects of deferoxamine on human myeloid leukemia cell lines. Cancer Res., 49:4809-4812, 1989.
    Poot M, Hoehn H.
    Cancer Res; 1990 Aug 15; 50(16):5204. PubMed ID: 2379180
    [No Abstract] [Full Text] [Related]

  • 4. DNA synthesis in leukemic cells under the action of cytotoxic agents in vitro and in vivo.
    Wilmanns W.
    Natl Cancer Inst Monogr; 1971 Dec 15; 34():153-9. PubMed ID: 5291099
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of proliferation of human leukaemic cell populations by deferoxamine.
    Foa P, Maiolo AT, Lombardi L, Villa L, Polli EE.
    Scand J Haematol; 1986 Jan 15; 36(1):107-10. PubMed ID: 3485303
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Suppression of HL-60 cell proliferation by deferoxamine: changes in c-myc expression.
    Tomoyasu S, Fukuchi K, Yajima K, Watanabe K, Suzuki H, Kawakami K, Gomi K, Tsuruoka N.
    Anticancer Res; 1993 Jan 15; 13(2):407-10. PubMed ID: 8517655
    [Abstract] [Full Text] [Related]

  • 9. Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells.
    Kulp KS, Vulliet PR.
    Toxicol Appl Pharmacol; 1996 Aug 15; 139(2):356-64. PubMed ID: 8806853
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
    Yang DC, Jiang XP, Elliott RL, Head JF.
    Anticancer Res; 2001 Aug 15; 21(3B):1777-87. PubMed ID: 11497259
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1alpha independent mechanisms.
    Guo M, Song LP, Jiang Y, Liu W, Yu Y, Chen GQ.
    Apoptosis; 2006 Jan 15; 11(1):67-77. PubMed ID: 16374551
    [Abstract] [Full Text] [Related]

  • 13. Characterization of human leukemia and Burkitt lymphoma cells by their acidic nuclear protein profiles.
    Weisenthal LM, Ruddon RW.
    Cancer Res; 1972 May 15; 32(5):1009-17. PubMed ID: 4502171
    [No Abstract] [Full Text] [Related]

  • 14. Assay of cell resistance to ara-C.
    Lacombe F.
    Methods Cell Biol; 1994 May 15; 42 Pt B():45-58. PubMed ID: 7533251
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of spin labeled derivatives of podophyllotoxin on cell cycle and macromolecular synthesis in human lymphoid leukemia Molt 4B cells.
    Wang JZ, Tsumura H, Shimura K, Tian X, Ito H.
    Zhongguo Yao Li Xue Bao; 1998 Nov 15; 19(6):501-5. PubMed ID: 10437132
    [Abstract] [Full Text] [Related]

  • 17. Effects of benzohydroxamic acids on L1210 lymphoid leukemia cell nucleic acid metabolism.
    Hall IH, Taylor K, Izydore RA, Daniels DL.
    Pharmazie; 1998 Nov 15; 53(11):794-9. PubMed ID: 9853360
    [No Abstract] [Full Text] [Related]

  • 18. Inhibitory effect of deferoxamine mesylate and low iron diet on the 13762NF rat mammary adenocarcinoma.
    Wang F, Elliott RL, Head JF.
    Anticancer Res; 1999 Nov 15; 19(1A):445-50. PubMed ID: 10226580
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antineoplastic effect of the xanthine derivative Trental.
    Biddle W, Ambrus CM, Gastpar H, Ambrus JL.
    J Med; 1984 Nov 15; 15(5-6):355-66. PubMed ID: 6336155
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.